BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29080523)

  • 1. Fatal poisonings involving propoxyphene before and after voluntary withdrawal from the United States' market: An analysis from the state of Florida.
    Delcher C; Chen G; Wang Y; Slavova S; Goldberger BA
    Forensic Sci Int; 2017 Nov; 280():228-232. PubMed ID: 29080523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
    Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
    JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in licit and illicit drug-related deaths in Florida from 2001 to 2012.
    Lee D; Delcher C; Maldonado-Molina MM; Bazydlo LA; Thogmartin JR; Goldberger BA
    Forensic Sci Int; 2014 Dec; 245():178-86. PubMed ID: 25447191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.
    Puet B; DePriest A; Knight J; Heltsley R; Black DL; Caplan YH; Cone EJ
    J Anal Toxicol; 2013; 37(1):1-4. PubMed ID: 23129731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Propoxyphene Market Withdrawal: Analgesic Substitutes, Doses, and Adverse Events.
    Jeffery MM; Morden NE; Larochelle M; Shah ND; Hooten WM; Meara E
    Med Care; 2020 Jan; 58(1):4-12. PubMed ID: 31651743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of propoxyphene withdrawal on opioid use in veterans.
    Hayes CJ; Hudson TJ; Phillips MM; Bursac Z; Williams JS; Austin MA; Edlund MJ; Martin BC
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1180-8. PubMed ID: 26248742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fatal poisonings by prescription opioids.
    Häkkinen M; Launiainen T; Vuori E; Ojanperä I
    Forensic Sci Int; 2012 Oct; 222(1-3):327-31. PubMed ID: 22884575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000 – 2011.
    Handley SA; Flanagan RJ
    Clin Toxicol (Phila); 2014 Jan; 52(1):1-12. PubMed ID: 24397714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study.
    Hawton K; Bergen H; Simkin S; Wells C; Kapur N; Gunnell D
    PLoS Med; 2012; 9(5):e1001213. PubMed ID: 22589703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Florida's Opioid Crackdown and Mortality From Drug Overdose, Motor Vehicle Crashes, and Suicide: A Bayesian Interrupted Time-Series Analysis.
    Feder KA; Mojtabai R; Stuart EA; Musci R; Letourneau EJ
    Am J Epidemiol; 2020 Sep; 189(9):885-893. PubMed ID: 32077469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics.
    Reset A; Skurtveit S; Furu K; Skovlund E
    Scand J Pain; 2018 Oct; 18(4):667-674. PubMed ID: 30145581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trend analysis of laboratory positive propoxyphene workplace urine drug screens before and after the product recall.
    Price J
    J Addict Med; 2015; 9(2):136-8. PubMed ID: 25622125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.
    Wilson N; Kariisa M; Seth P; Smith H; Davis NL
    MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(11):290-297. PubMed ID: 32191688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds: the USA experience.
    Finkle BS
    Hum Toxicol; 1984 Aug; 3 Suppl():115S-134S. PubMed ID: 6480011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deaths related to propoxyphene overdose: a ten-year assessment.
    Wetli CV; Bednarczyk LR
    South Med J; 1980 Sep; 73(9):1205-9. PubMed ID: 7414379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food and Drug Administration recommends against the continued use of propoxyphene.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2011; 25(1):80-2. PubMed ID: 21426228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal poisonings in Jutland (Denmark) during the 1980s.
    Kaa E; Gregersen M
    Int J Legal Med; 1992; 105(3):133-8. PubMed ID: 1419873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices.
    Hargrove SL; Bunn TL; Slavova S; Quesinberry D; Corey T; Ralston W; Singleton MD; Ingram V
    Inj Prev; 2018 Feb; 24(1):60-67. PubMed ID: 28739777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program.
    Delcher C; Wagenaar AC; Goldberger BA; Cook RL; Maldonado-Molina MM
    Drug Alcohol Depend; 2015 May; 150():63-8. PubMed ID: 25746236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
    Rudd RA; Aleshire N; Zibbell JE; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.